In our analysis, patients with increased DYRK1B expression levels showed several significant features of heart failure with reduced ejection fraction (HFrEF), while there were no differences in age, gender distribution, BMI, diabetes mellitus, atrial fibrillation, renal function, coronary artery status, or patient treatment (Table 1). Here, DYRK1B is linked to heart failure.